Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Alnylam Pharmaceuticals Inc ALNY

Sector: Healthcare | Sub-Sector: Biotechnology

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Price: $54.50 | Change: +$1.28 | % Change: +2.41%
Volume: 369,909 | Day High/Low: 55.66/53.10 | 52 Week High/Low: 112.57/21.60
top

Snapshot

Last Traded: April 16, 2014 08:48 Transaction Volume: 369,909
Open: $54.50 Previous Close: $53.22
Bid: $54.45 Ask: $54.70
Bid Size: 200 Ask Size: 300
Market Cap: $3.5b Shares Out: 63.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • Stepping up today

    0 stars

    I am getting my feet wet in this as I believe it is on the threshold of some exciting developments with respect to 'RNA Interference...

    2.5 stars


  • ALNY Short Squeeze

    0 stars

    With the press release today, there's a squeeze happening with the ALNY short-sellers.  Volume has hit approximately 3.5 million today...

    1.5 stars


  • Bought last week

    0 stars

    Alnylam announced last Tuesday that it has filed to sell 7.5 million shares of common stock at $10.75 a share, with the intent of raising...

    0 stars


  • Not gonna be good ALNY

    0 stars

    TKM gets an injunction from BC coutrs for alleged documents pilfered from TKM computer files. Wil carry substantial wieght IMO in the...

    2 stars


  • Tekmira receives milestone payments for ALN-TTR01

    0 stars

    Tekmira receives milestone payments of up to US$16 from Alnylam for TTR01...From Tekmira Website:"Alnylam has broad access to Tekmira’s...

    2.5 stars